Sponsored Links
| Gloucester Pharmaceuticals To Present Positive Results From Multiple Studies Of ISTODAX(R) At The ASH Annual Meeting |
 |
 |
 |
| Medical News - Hematology | |||
|
Gloucester Pharmaceuticals announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N. Morial Convention Center, December 5 - 8, 2009. ISTODAX, a novel histone deacetylase (HDAC) inhibitor, was recently approved by the U.S... Read more: Blood / Hematology News From Medical News Today
|